Metastatic Urothelial Cancer and Other Malignant Solid Tumors Clinical Trials

Metastatic Urothelial Cancer and Other Malignant Solid Tumors

Explore clinical trials studying Metastatic Urothelial Cancer and Other Malignant Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Metastatic Urothelial Cancer and Other Malignant Solid Tumors trial results

Completed

A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4

NCT02091999

Conditions: Metastatic Urothelial Cancer and Other Malignant Solid Tumors
Locations: Site US00012 Los Angeles, California, United States

Site US00019 Stanford, California, United States

Site US00017 Aurora, Colorado, United States

Site US00006 New Haven, Connecticut, United States

View all 21 locations

View Trial Details